Cargando…
Advances in nuclear medicine-based molecular imaging in head and neck squamous cell carcinoma
Head and neck squamous cell carcinomas (HNSCCs) are often aggressive, making advanced disease very difficult to treat using contemporary modalities, such as surgery, radiation therapy, and chemotherapy. However, targeted therapy, e.g., cetuximab, an epidermal growth factor receptor inhibitor, has de...
Autores principales: | Li, Danni, Li, Xuran, Zhao, Jun, Tan, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373390/ https://www.ncbi.nlm.nih.gov/pubmed/35962347 http://dx.doi.org/10.1186/s12967-022-03559-5 |
Ejemplares similares
-
Plasma oncology: Adjuvant therapy for head and neck cancer using cold atmospheric plasma
por: Li, Xuran, et al.
Publicado: (2022) -
Targeted molecular imaging of head and neck squamous cell carcinoma: a window into precision medicine
por: Wu, Jun, et al.
Publicado: (2020) -
Development of a fibroblast activation protein-targeted PET/NIR dual-modality probe and its application in head and neck cancer
por: Li, Danni, et al.
Publicado: (2023) -
A Prognostic Model of Head and Neck Cancer Based on Amino Acid Metabolism-Related Signature and Its Implication for Immunosuppressive Microenvironment
por: Li, Xuran, et al.
Publicado: (2023) -
Genomics and advances towards precision medicine for head and neck squamous cell carcinoma
por: Van Waes, Carter, et al.
Publicado: (2017)